de Jong T, Semmelink J, Denis S, Bolt J, Maas M, van de Sande M
Cells. 2023; 12(1).
PMID: 36611795
PMC: 9818527.
DOI: 10.3390/cells12010001.
Siddique R, Mehmood M, Haris M, Saleem A, Chaudhry Z
Inflammopharmacology. 2022; 30(4):1207-1218.
PMID: 35524837
DOI: 10.1007/s10787-022-00997-x.
Anang D, Ramwadhdoebe T, Hahnlein J, van Kuijk B, Smits N, van Lienden K
Cells. 2022; 11(7).
PMID: 35406668
PMC: 8997933.
DOI: 10.3390/cells11071104.
Nikolakis D, de Voogd F, Pruijt M, Grootjans J, van de Sande M, DHaens G
Int J Mol Sci. 2022; 23(3).
PMID: 35163775
PMC: 8836364.
DOI: 10.3390/ijms23031854.
Fiechter R, Bolt J, van de Sande M, Aalbers C, Landewe R, Maas M
Arthritis Res Ther. 2022; 24(1):36.
PMID: 35115042
PMC: 8812012.
DOI: 10.1186/s13075-022-02728-7.
Bridging Insights From Lymph Node and Synovium Studies in Early Rheumatoid Arthritis.
OByrne A, de Jong T, van Baarsen L
Front Med (Lausanne). 2022; 8:820232.
PMID: 35096912
PMC: 8795611.
DOI: 10.3389/fmed.2021.820232.
Human Lymph Node Stromal Cells Have the Machinery to Regulate Peripheral Tolerance during Health and Rheumatoid Arthritis.
Hahnlein J, Nadafi R, de Jong T, Semmelink J, Remmerswaal E, Safy M
Int J Mol Sci. 2020; 21(16).
PMID: 32784936
PMC: 7460812.
DOI: 10.3390/ijms21165713.
Multi-HLA class II tetramer analyses of citrulline-reactive T cells and early treatment response in rheumatoid arthritis.
Gerstner C, Turcinov S, Hensvold A, Chemin K, Uchtenhagen H, Ramwadhdoebe T
BMC Immunol. 2020; 21(1):27.
PMID: 32423478
PMC: 7236297.
DOI: 10.1186/s12865-020-00357-w.
Phenotypic Analysis of Human Lymph Nodes in Subjects With New-Onset Type 1 Diabetes and Healthy Individuals by Flow Cytometry.
Yang J, Khatri L, Mickunas M, Williams E, Tatovic D, Ali M
Front Immunol. 2019; 10:2547.
PMID: 31749806
PMC: 6842967.
DOI: 10.3389/fimmu.2019.02547.
Molecular Characterization of Human Lymph Node Stromal Cells During the Earliest Phases of Rheumatoid Arthritis.
Karouzakis E, Hahnlein J, Grasso C, Semmelink J, Tak P, Gerlag D
Front Immunol. 2019; 10:1863.
PMID: 31481955
PMC: 6711342.
DOI: 10.3389/fimmu.2019.01863.
Myeloid Dendritic Cells Are Enriched in Lymph Node Tissue of Early Rheumatoid Arthritis Patients but not in At Risk Individuals.
Ramwadhdoebe T, Ramos M, Maijer K, van Lienden K, Maas M, Gerlag D
Cells. 2019; 8(7).
PMID: 31330824
PMC: 6679555.
DOI: 10.3390/cells8070756.
Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis.
Ramwadhdoebe T, van Baarsen L, Boumans M, Bruijnen S, Safy M, Berger F
Rheumatology (Oxford). 2019; 58(6):1075-1085.
PMID: 30649469
PMC: 6532448.
DOI: 10.1093/rheumatology/key428.
Impaired lymph node stromal cell function during the earliest phases of rheumatoid arthritis.
Hahnlein J, Nadafi R, de Jong T, Ramwadhdoebe T, Semmelink J, Maijer K
Arthritis Res Ther. 2018; 20(1):35.
PMID: 29482663
PMC: 5828373.
DOI: 10.1186/s13075-018-1529-8.
Distinctive expression of T cell guiding molecules in human autoimmune lymph node stromal cells upon TLR3 triggering.
Hahnlein J, Ramwadhdoebe T, Semmelink J, Choi I, Berger F, Maas M
Sci Rep. 2018; 8(1):1736.
PMID: 29379035
PMC: 5789053.
DOI: 10.1038/s41598-018-19951-5.
Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start?.
Tracy A, Buckley C, Raza K
Semin Immunopathol. 2017; 39(4):423-435.
PMID: 28337522
PMC: 5486797.
DOI: 10.1007/s00281-017-0620-6.
Computational Model Reveals Limited Correlation between Germinal Center B-Cell Subclone Abundancy and Affinity: Implications for Repertoire Sequencing.
Reshetova P, van Schaik B, Klarenbeek P, Doorenspleet M, Esveldt R, Tak P
Front Immunol. 2017; 8:221.
PMID: 28321219
PMC: 5337809.
DOI: 10.3389/fimmu.2017.00221.
B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients.
Bruijnen S, Tsang-A-Sjoe M, Raterman H, Ramwadhdoebe T, Vugts D, van Dongen G
Arthritis Res Ther. 2016; 18(1):266.
PMID: 27863504
PMC: 5116204.
DOI: 10.1186/s13075-016-1166-z.
Lymph node biopsy analysis reveals an altered immunoregulatory balance already during the at-risk phase of autoantibody positive rheumatoid arthritis.
Ramwadhdoebe T, Hahnlein J, Maijer K, van Boven L, Gerlag D, Tak P
Eur J Immunol. 2016; 46(12):2812-2821.
PMID: 27645315
PMC: 5157721.
DOI: 10.1002/eji.201646393.
Brief Report: Altered Innate Lymphoid Cell Subsets in Human Lymph Node Biopsy Specimens Obtained During the At-Risk and Earliest Phases of Rheumatoid Arthritis.
Rodriguez-Carrio J, Hahnlein J, Ramwadhdoebe T, Semmelink J, Choi I, van Lienden K
Arthritis Rheumatol. 2016; 69(1):70-76.
PMID: 27428460
PMC: 6681066.
DOI: 10.1002/art.39811.
Human lymph-node CD8(+) T cells display an altered phenotype during systemic autoimmunity.
Ramwadhdoebe T, Hahnlein J, van Kuijk B, Choi I, van Boven L, Gerlag D
Clin Transl Immunology. 2016; 5(4):e67.
PMID: 27195110
PMC: 4855272.
DOI: 10.1038/cti.2016.8.
